PREVALENCE OF PERSISTENT LIPID ABNORMALITIES IN HIGH-RISK PATIENTS TREATED WITH STATINS: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY IN THE UK

被引：0
|
作者：
Kotseva, K. [1 ]
Bowker, T. [2 ]
Jennings, C. [1 ]
Turner, E. [3 ]
Amber, V. [1 ]
Wood, D. [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Homerton Univ Hosp NHS Trust, Dept Cardiol, London, England
[3] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1, England
来源：
HEART | 2010年 / 96卷
关键词：
D O I：
10.1136/hrt.2010.196089.11
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [41] Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
    Anselm K. Gitt
    Claus Jünger
    Wenefrieda Smolka
    Kurt Bestehorn
    Clinical Research in Cardiology, 2010, 99 : 723 - 733
  • [42] Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
    Gitt, Anselm K.
    Juenger, Claus
    Smolka, Wenefrieda
    Bestehorn, Kurt
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (11) : 723 - 733
  • [43] Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study
    Jameson, K.
    Amber, V.
    D'Oca, K.
    Mills, D.
    Giles, A.
    Ambegaonkar, B.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1228 - 1237
  • [44] Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care
    Bestehorn, Kurt
    Smolka, Wenefrieda
    Pittrow, David
    Schulte, Helmut
    Assmann, Gerd
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (12) : 2833 - 2839
  • [45] Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy
    De Ferrari, Gaetano M.
    Perna, Gian P.
    Nicosia, Antonino
    Guasti, Luigina
    Casu, Gavino
    Cuccia, Claudio
    Picco, Francesca
    Strazzella, Caterina
    Totaro, Rossana
    Cercone, Stefania
    Canullo, Laura
    Horack, Martin
    Lautsch, Dominik
    Gitt, Anselm K.
    Di Biase, Matteo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (09) : 485 - 490
  • [46] Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece
    Fragoulakis, Vassilis
    Kourlaba, Georgia
    Maniadakis, Nikolaos
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 135 - 143
  • [47] High-density lipoprotein as a marker of residual risk in patients treated with statins: prevalence and clinical importance
    Lahoz Rallo, C.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 : 9 - 11
  • [48] STILL HIGH PREVALENCE OF PERSISTENT LIPID ABNORMALITIES AMONG CORONARY PATIENTS DESPITE CHRONIC STATIN THERAPY IN 2014: RESULTS OF DYSIS II ACS AND CHD
    Gitt, Anselm K.
    Lautsch, Dominik
    Ambegaonkar, Baishali
    Horack, Martin
    Brudi, Philippe
    Ferrieres, Jean
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2040 - 2040
  • [49] PREVALENCE OF LOW HDL-C IN STATIN TREATED PATIENTS - THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)
    Millan, J.
    Gonzalez-Juanatey, J. R.
    Alegria, E.
    Guijarro, C.
    Gonzalez-Timon, B.
    Vitale, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 50 - 50
  • [50] Clinical Significance of Mild Lipid-Lowering by Statins for Prevention of Cardiovascular Disease in Japanese High-Risk Patients
    Miyazaki, Tetsuro
    Daida, Hiroyuki
    CIRCULATION JOURNAL, 2010, 74 (04) : 630 - 631
12345